Saroj Namrata 4
4 · OCULAR THERAPEUTIX, INC · Filed Nov 7, 2025
Insider Transaction Report
Form 4
Saroj Namrata
Chief Business Officer
Transactions
- Sale
Common Stock
2025-11-05$10.74/sh−25,865$277,790→ 174,135 total
Footnotes (2)
- [F1]Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 4, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on November 4, 2025. The sales do not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.5875 to $10.8704, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.